Nevro Management

Management criteria checks 1/4

Nevro's CEO is Kevin Thornal, appointed in Apr 2023, has a tenure of 1.75 years. total yearly compensation is $11.45M, comprised of 4.5% salary and 95.5% bonuses, including company stock and options. directly owns 0.084% of the company’s shares, worth $117.01K. The average tenure of the management team and the board of directors is 1.9 years and 5.5 years respectively.

Key information

Kevin Thornal

Chief executive officer

US$11.5m

Total compensation

CEO salary percentage4.5%
CEO tenure1.8yrs
CEO ownership0.08%
Management average tenure1.9yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Little Excitement Around Nevro Corp.'s (NYSE:NVRO) Revenues As Shares Take 34% Pounding

Aug 11
Little Excitement Around Nevro Corp.'s (NYSE:NVRO) Revenues As Shares Take 34% Pounding

Nevro: Not Having My Back

Aug 09

Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Jul 16
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Nevro Corp. (NYSE:NVRO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

May 01
Nevro Corp. (NYSE:NVRO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?

Feb 25
Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?

There Is A Reason Nevro Corp.'s (NYSE:NVRO) Price Is Undemanding

Jan 08
There Is A Reason Nevro Corp.'s (NYSE:NVRO) Price Is Undemanding

Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?

Nov 16
Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?

Nevro: Economic Realities Too Deep To Ignore, Downgrade To Hold

Sep 01

Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Jul 10
Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Investors Shouldn't Be Too Comfortable With Nevro's (NYSE:NVRO) Robust Earnings

Feb 28
Investors Shouldn't Be Too Comfortable With Nevro's (NYSE:NVRO) Robust Earnings

Nevro falls to 52-week low; down ~49% over last year

Feb 22

Nevro: Treating Patient Back Pains, Causing Shareholder Back Pains

Feb 14

Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Jan 13
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Nevro: Opportunity Overshadowed By Weaknesses

Dec 07

Boston Scientific drives rival Nevro lower after remarks on neuromodulation

Oct 26

Nevro's Senza spinal cord stimulation system for chronic pain gets FDA approval

Oct 13

Nevro gets FDA approval for Costa Rica manufacturing operations

Oct 04

Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Oct 02
Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Nevro: Niche Operator In Neuropathy, Reluctant Hold On Valuation

Sep 07

Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Jun 17
Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

CEO Compensation Analysis

How has Kevin Thornal's remuneration changed compared to Nevro's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$69m

Jun 30 2024n/an/a

-US$77m

Mar 31 2024n/an/a

-US$83m

Dec 31 2023US$11mUS$516k

-US$92m

Compensation vs Market: Kevin's total compensation ($USD11.45M) is above average for companies of similar size in the US market ($USD649.25K).

Compensation vs Earnings: Insufficient data to compare Kevin's compensation with company performance.


CEO

Kevin Thornal (50 yo)

1.8yrs

Tenure

US$11,453,548

Compensation

Mr. Kevin R. Thornal serves as President & Chief Executive Officer at Nevro Corp. since April 24, 2023 and serves as its Director since May 2023. He joined Nevro Corp. on April 24, 2023. He serves as Acti...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Thornal
President1.8yrsUS$11.45m0.084%
$ 117.0k
Roderick MacLeod
Senior VP & CFO4.6yrsUS$2.58m0.072%
$ 100.4k
Kashif Rashid
Senior VP of Corporate Development & Chief Legal Officer7.1yrsUS$2.55m0.14%
$ 190.5k
Greg Siller
Senior VP & Chief Commercial Officer1.6yrsUS$3.56m0.068%
$ 95.1k
Christofer Christoforou
Senior VP & COOless than a yearUS$2.87m0.082%
$ 113.9k
Angeline McCabe
Vice President of Investor Relations & Corporate Communicationsless than a yearno datano data
Shana Ross
Senior VP & Chief Human Resources Officer2yrsno datano data
David Caraway
Senior VP & Chief Medical Officer10.8yrsno datano data
Peter Socarras
VP, General Counsel & Corporate Secretaryno datano datano data

1.9yrs

Average Tenure

50.5yo

Average Age

Experienced Management: NVRO's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Kevin Thornal
President1.7yrsUS$11.45m0.084%
$ 117.0k
Susan Siegel
Independent Director4.1yrsUS$242.99k0.034%
$ 47.6k
Shawn McCormick
Independent Director10.3yrsUS$246.99k0.072%
$ 99.9k
Elizabeth Weatherman
Independent Director5.8yrsUS$259.24k0.16%
$ 229.4k
D. Grossman
Non-Executive Chairman of the Board5.8yrsUS$1.48m0.53%
$ 740.1k
Michael DeMane
Independent Lead Director13.8yrsUS$284.99k1.27%
$ 1.8m
Kevin O'Boyle
Independent Director5.8yrsUS$259.99k0.065%
$ 90.1k
Kirt Karros
Independent Directorless than a yearno datano data
Karen Prange
Independent Director5.1yrsUS$252.99k0.039%
$ 55.0k
Sridhar Kosaraju
Independent Director3.3yrsUS$242.99k0.062%
$ 86.2k

5.5yrs

Average Tenure

61.5yo

Average Age

Experienced Board: NVRO's board of directors are considered experienced (5.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:24
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nevro Corp. is covered by 26 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RescottBaird
null nullBaird
Michael PolarkBaird